54 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Fulcrum Therapeutics, Inc. FULC climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
• Lightning eMotors, Inc. ZEV shares jumped 64.2% to $10.53 after the company reported a multi-year deal with Forest River for zero-emission bus technology, charging products and services. The deal is valued at up to $850 million.
• Allied Healthcare Products, Inc. AHPI shares climbed 49.8% to $15.16 after jumping around 23% on Monday.
• 3D Systems Corporation DDD shares rose 30.1% to $36.88 after the company reported better-than-expected results for its second quarter on Monday.
• Myomo, Inc. MYO rose 27.1% to $9.98 after reporting upbeat Q2 results.
• Exagen Inc. XGN gained 25.8% to $12.90 following upbeat Q2 results.
• MediaCo Holding Inc. MDIA rose 26% to $9.34.
• Arcturus Therapeutics Holdings Inc. ARCT shares rose 23.9% to $59.77 after the company reported better-than-expected Q2 earnings and also said ARCT-021 will begin multinational placebo-controlled Phase 3 efficacy study funded & sponsored by a global entity.
• Dynatronics Corporation DYNT jumped 20% to $1.56 after the company reported strong preliminary sales for the fourth quarter.
• Fisker Inc. FSR rose 19.1% to $17.90. Morgan Stanley resumed covered on the stock with a Buy rating and a $40 price target and set its bull-case scenario at $90.
• Pixelworks, Inc. PXLW gained 18.3% to $3.61. Pixelworks is expected to release its Q2 financial results on August 10, 2021 after the closing bell.
• Harmony Biosciences Holdings, Inc. HRMY jumped 16.5% to $31.20 after reporting upbeat quarterly results. Harmony Biosciences and Blackstone entered into Strategic financing collaboration for up to $330 million.
• Agrify Corporation AGFY surged 15.8% to $26.20. Agrify is expected to report its financial results for the second quarter on August 12, 2021.
• Albertsons Companies, Inc. ACI gained 13.2% to $28.06 after the company said Sharon McCollam will join the Company as its President and Chief Financial Officer.
• Array Technologies, Inc. ARRY gained 13.2% to $15.52. Roth Capital analyst Philip Shen upgraded Array Technologies to Buy from Neutral with a $25 price target, implying an upside of 82.3%.
• Model N, Inc. MODN jumped 12.2% to $36.56 after the company reported upbeat Q3 results and issued strong Q4 forecast.
• Turning Point Therapeutics, Inc. TPTX gained 9.8% to $68.13 following Q2 earnings.
• The Trade Desk, Inc. TTD rose 8.7% to $88.44. Several analysts raised their price targets on Trade Desk.
• AerSale Corporation ASLE surged 8.7% to $12.61. AerSale, last week, reported second-quarter revenue growth of 102.7% year-over-year to $91.91 million, beating the consensus of $77.28 million.
• Calliditas Therapeutics AB CALT rose 8% to $31.96. The FDA granted Fast Track Designation to Calliditas Therapeutics lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).
• Kansas City Southern KSU rose 7.4% to $289.59 following a report suggesting Canadian Pacific plans a new higher bid for the company, near $300 per share.
• Purple Innovation, Inc. PRPL rose 6.7% to $26.40 after the company swung to a profit in the second quarter. The company also issued FY21 sales guidance.
• Lufax Holding Ltd LU rose 5.3% to $7.88 after reporting upbeat quarterly earnings.
• Kaixin Auto Holdings KXIN jumped 4.2% to $3.0301 after the company announced entry into the smaller size electric vehicle (EV) market in China. Kaixin is also discussing mergers and acquisitions with several electric car manufacturers to speed up the process.

Check out these big penny stock gainers and losers

Losers

• Katapult Holdings, Inc. KPLT shares dipped 50.9% to $4.7810 after the company reported Q2 earnings results.
• EyeGate Pharmaceuticals, Inc. EYEG shares declined 22.5% to $1.76 after the company announced a $10.75 million registered direct offering priced at-the-market under Nasdaq rules.
• SmileDirectClub, Inc. SDC fell 22.5% to $5.20 after the company reported worse-than-expected Q2 results and issued FY21 sales guidance below estimates.
• Metromile, Inc. MILE shares dipped 22.5% to $5.41 after the company reported a wider-than-expected Q2 loss.
• comScore, Inc. SCOR fell 20.8% to $3.19 after the company reported a wider-than-expected Q2 loss.
• Waitr Holdings Inc. WTRH fell 18.9% to $1.29 after the company reported downbeat Q2 results. The company also reported the purchase of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC.
• PARTS iD, Inc. ID dipped 18.8% to $5.85 following weaker-than-expected Q2 results.
• The RealReal, Inc. REAL fell 18.4% to $13.25 after the company reported worse-than-expected Q2 results.
• Vuzix Corporation VUZI fell 18% to $11.26 after the company reported worse-than-expected Q2 results.
• Washington Prime Group Inc. WPG fell 17.9% to $1.3793 after the company reported Q2 earnings results.
• Vuzix Corporation VUZI dipped 17.6% to $11.31. Vuzix reported its second quarter results for the period ended June 30, 2021.
• Casper Sleep Inc. CSPR fell 17.3% to $5.72 after reporting a wider-than-expected quarterly loss.
• Liminal BioSciences Inc. LMNL fell 16.9% to $3.0350. Liminal BioSciences jumped around 28% on Monday as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million.
• Star Equity Holdings, Inc. STRR dropped 16.7% to $2.98 after the company posted a wider quarterly loss.
• Aterian, Inc. ATER dipped 16.6% to $4.5800. Aterian S-1 showed registration for 2.7 million share common stock offering via selling shareholders. Roth Capital downgraded Aterian from Buy to Neutral and announced a $5.5 price target.
• Reata Pharmaceuticals, Inc. RETA fell 16.6% to $101.83 after the company reported Q2 earnings and provided an update on clinical development programs.
• Oak Street Health, Inc. OSH dropped 16.5% to $52.54 after the company reported worse-than-expected Q2 EPS results.
• Yalla Group Limited YALA shares declined 16.5% to $11.32 following weak quarterly sales.
• AudioEye, Inc. AEYE dropped 15.3% to $12.23. The company is expected to release quarterly earnings on August 11, 2021.
• FedNat Holding Company FNHC dipped 15.2% to $2.1620 after reporting a wider quarterly loss.
• Talkspace, Inc. TALK fell 15% to $5.03 following Q2 loss.
• Fulgent Genetics, Inc. FLGT shares fell 14.8% to $93.47 after the company reported worse-than-expected Q2 results. Fulgent Genetics and Helio Health also reported a partnership to commercialize early cancer detection tests.
• Origin Agritech Limited SEED declined 13.8% to $11.65.
• Cano Health, Inc. CANO fell 13.2% to $10.12.
• Nautilus, Inc. NLS dropped 12.5% to $12.53. Nautilus reported first-quarter FY22 sales growth of 61.7% year-on-year. Craig-Hallum downgraded Nautilus from Buy to Hold.
• Inovio Pharmaceuticals, Inc. INO fell 12.4% to $8.41 after the company reported worse-than-expected Q2 results.
• CarLotz, Inc. LOTZ fell 11.5% to $4.1550 after the company reported it withdrew previously-issued FY21 guidance, citing "channel constraints."
• CareMax, Inc. CMAX dropped 9.9% to $8.55.
• BioCryst Pharmaceuticals, Inc. BCRX shares fell 9.3% to $16.01 after the company announced it commenced a public offering of $200 million of common stock and pre-funded warrants.
• Senseonics Holdings, Inc. SENS shares fell 8.3% to $2.9799 after the company reported Q2 earnings results and issued FY21 guidance.